Japan-based Maruho Co Ltd has named Atsushi Sugita as its new president and chief executive officer, effective 18 December 2020, it was reported on Friday.
Sugita is to replace Koichi Takagi who will remain with the company as chairman of the board.
Sugita has served at Johnson & Johnson's US headquarters and Janssen Japan. He held various positions at Maruho's R&D Labs, Head Office, and global subsidiaries.
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign